» Authors » Michael Sullivan

Michael Sullivan

Explore the profile of Michael Sullivan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 128
Citations 3775
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Harrop S, Casan J, Rose H, Sullivan M, Mehr S, Ngu H, et al.
Br J Haematol . 2025 Mar; PMID: 40031954
Germline homozygous loss-of-function mutations in TET2 result in significant childhood immunodeficiency that resembles autoimmune lymphoproliferative syndrome and predisposes one to lymphoma. The implications of heterozygous variants are less well understood....
2.
Raj T, Harrison J, Wakefield C, Daur B, Felmingham B, Casey M, et al.
J Glob Health . 2025 Feb; 15:03008. PMID: 39946562
Childhood cancer outcomes in low- and middle-income countries are impacted by the presentation of advanced disease and limited diagnostic and treatment resources. Papua New Guinea is highly populated with significant...
3.
Cabrera V, Bewley J, Breunig M, Breunig T, Cooley W, De Vries A, et al.
Animals (Basel) . 2025 Feb; 15(3). PMID: 39943099
The dairy industry faces significant challenges in data integration and analysis, which are critical for informed decision-making, operational optimization, and sustainability. Data integration-combining data from diverse sources, such as herd...
4.
Sniderman E, Reljic T, Bhakta M, Bonilla M, Clyce J, Farmer J, et al.
Cancer Med . 2024 Nov; 13(21):e70377. PMID: 39499026
Introduction: Optimal outcomes during childhood cancer treatment require effective management of toxicities, often called supportive care. A lack of agreement on what comprises supportive care limits the development and provision...
5.
Toro C, Felmingham B, Jessop S, Celermajer D, Kotecha R, Govender D, et al.
JACC Adv . 2024 Jun; 1(5):100155. PMID: 38939459
Cardio-oncology is a new multidisciplinary area of expertise that seeks to pre-emptively and proactively address cardiac complications that emerge during and following cancer therapy. Modern therapies including molecular targeted therapy...
6.
Fukushima A, Hande V, Wakeham K, Barton M, Zaghloul M, Moreira D, et al.
Radiother Oncol . 2024 May; 197:110343. PMID: 38806114
Background And Purpose: The optimal utilization rate of radiotherapy (oRUR) serves as a benchmark for assessing service demand and improving access to cancer care. While it is estimated that approximately...
7.
Lau L, Allingham C, Anazodo A, Sullivan M, Peate M, Hunter S, et al.
Pediatr Blood Cancer . 2024 May; 71(7):e31041. PMID: 38715224
International and national oncofertility networks, including the US-led Oncofertility Consortium, FertiProtekt, and the Danish Network, have played pivotal roles in advancing the discipline of oncofertility over the last decade. Many...
8.
Meijer A, Diepstraten F, Ansari M, Bouffet E, Bleyer A, Fresneau B, et al.
J Clin Oncol . 2024 Apr; 42(18):2219-2232. PMID: 38648563
Purpose: Hearing loss occurs in 50%-70% of children treated with cisplatin. Scientific efforts have led to the recent approval of a pediatric formula of intravenous sodium thiosulfate (STS) for otoprotection...
9.
Adamson W, Noyes H, Johnson P, Cooper A, Monckton D, Ogunsola J, et al.
EBioMedicine . 2024 Feb; 101:105000. PMID: 38360481
Background: APOL1 variants G1 and G2 are common in populations with recent African ancestry. They are associated with protection from African sleeping sickness, however homozygosity or compound heterozygosity for these...
10.
Ahler A, Gook D, Moussaoui D, Archer J, Zacharin M, DArcy C, et al.
Reprod Biomed Online . 2023 Jun; 47(2):103232. PMID: 37301710
Research Question: Is there potential for the detection of neuroblastoma malignancy in testicular tissue extracted for fertility preservation for prepubertal boys at the time of tissue freezing? Design: This is...